Pfizer Japan Preps For Local Mergers, Calls For Policy Debate
This article was originally published in PharmAsia News
Executive Summary
Pfizer in Japan says little about the integration plans for Hospira and the local merger with Allergan as it reports a modest rise in sales in this key market and calls for a policy debate that focuses on supporting innovation and disease prevention.